Home LiteratureArticle Details
PMID: 1346931 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

p185c-neu and epidermal growth factor receptor associate into a structure composed of activated kinases.

Quian XL, Decker SJ, Greene MI

Abstract

The protein product of the neu protooncogene, p185c-neu, is structurally similar to the epidermal growth factor receptor (EGFR). Overexpression of these two receptor tyrosine kinases, but not either separately, leads to transformation and tumorigenicity. Heterodimerization of p185c-neu and EGFR occurs in M1 cells, which express both receptors. We have individually identified the two components of the heterodimer as EGFR and p185c-neu. Analysis of this association with relatively nondenaturing detergents and in the absence of cross-linkers indicates that noncovalent interactions are primarily responsible for heterodimer formation. The rapid reversible heterodimerization was promoted by EGF binding to its receptor. Functionally, the heterodimer is a highly active protein kinase for receptor autophosphorylation and exogenous substrate phosphorylation in vitro. The isolated heterodimer was highly phosphorylated on tyrosine residues in vivo. These results indicate that the physical association between EGFR and p185c-neu is of functional significance and define enzymatic features of complex receptor formation.

MeSH Terms
Cross-Linking Reagents Enzyme Activation ErbB Receptors/metabolism Humans In Vitro Techniques Ligands Macromolecular Substances Protein-Tyrosine Kinases/metabolism Proto-Oncogene Proteins/metabolism Receptor Aggregation Receptor, ErbB-2 Signal Transduction Structure-Activity Relationship Transfection
Chemicals
Cross-Linking Reagents Ligands Macromolecular Substances Proto-Oncogene Proteins ErbB Receptors Protein-Tyrosine Kinases Receptor, ErbB-2
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Quian X L
Department of Biology, University of Pennsylvania, School of Medicine, Philadelphia 19104-6082.
Decker S J
Greene M I
References (30)
30 references, click to expand
  1. Transforming growth factor alpha.
    Cell. 1988 Aug 26;54(5):593-5 PMID: 3044605
  2. Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.
    EMBO J. 1988 Jun;7(6):1647-51 PMID: 2901952
  3. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor.
    Biochemistry. 1987 Mar 10;26(5):1443-51 PMID: 3494473
  4. The neu oncogene encodes an epidermal growth factor receptor-related protein.
    Nature. 1986 Jan 16-22;319(6050):226-30 PMID: 3945311
  5. Internalization and degradation of receptor-bound human choriogonadotropin in Leydig tumor cells. Fate of the hormone subunits.
    J Biol Chem. 1982 Nov 25;257(22):13306-11 PMID: 6292185
  6. Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.
    J Biol Chem. 1984 Apr 25;259(8):5287-94 PMID: 6325430
  7. Platelet-derived growth factor (PDGF) stimulates PDGF receptor subunit dimerization and intersubunit trans-phosphorylation.
    J Biol Chem. 1991 May 15;266(14):8987-92 PMID: 1709159
  8. p185neu expression in human lung adenocarcinomas predicts shortened survival.
    Cancer Res. 1990 Aug 15;50(16):5184-7 PMID: 1974168
  9. A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerization.
    Protein Eng. 1990 Mar;3(4):245-8 PMID: 2160658
  10. Stimulation of phospholipase C-gamma 1 membrane association by epidermal growth factor.
    Science. 1990 Jul 20;249(4966):296-8 PMID: 2374928
  11. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts.
    Cell. 1989 Jul 28;58(2):287-92 PMID: 2568888
  12. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.
    J Steroid Biochem. 1989;34(1-6):123-31 PMID: 2576295
  13. Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.
    Cell. 1985 Jul;41(3):697-706 PMID: 2860972
  14. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93 PMID: 2899889
  15. The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor.
    Science. 1985 Sep 6;229(4717):976-8 PMID: 2992090
  16. EGF-stimulated tyrosine phosphorylation of p185neu: a potential model for receptor interactions.
    EMBO J. 1988 Apr;7(4):995-1001 PMID: 3261240
  17. Mechanism of epidermal growth factor receptor autophosphorylation and high-affinity binding.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):7832-6 PMID: 3500470
  18. Multiple immunoreplica Technique: screening for specific proteins with a series of different antibodies using one polyacrylamide gel.
    Anal Biochem. 1981 Mar 1;111(2):385-92 PMID: 6166216
  19. Characterization of a neu/c-erbB-2 protein-specific activating factor.
    Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8582-6 PMID: 1717981
  20. Intermolecular association of the p185neu protein and EGF receptor modulates EGF receptor function.
    Cell. 1990 Jun 29;61(7):1339-47 PMID: 1973074
  21. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation.
    Biochemistry. 1990 Dec 18;29(50):11024-8 PMID: 1980216
  22. Signal transduction by receptors with tyrosine kinase activity.
    Cell. 1990 Apr 20;61(2):203-12 PMID: 2158859
  23. Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells.
    Mol Cell Biol. 1990 Aug;10(8):4035-44 PMID: 2164634
  24. Experimental approaches to hypothetical hormones: detection of a candidate ligand of the neu protooncogene.
    Proc Natl Acad Sci U S A. 1989 May;86(9):3179-83 PMID: 2470093
  25. Effects of platelet-derived growth factor on phosphorylation of the epidermal growth factor receptor in human skin fibroblasts.
    J Biol Chem. 1989 Jun 5;264(16):9204-9 PMID: 2470752
  26. Differential regulation of oncogenic and cellular p185 by serine/threonine kinases.
    DNA. 1989 Dec;8(10):723-32 PMID: 2575488
  27. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation.
    Nature. 1989 May 18;339(6221):230-1 PMID: 2654648
  28. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
    Cell. 1986 Jun 6;45(5):649-57 PMID: 2871941
  29. Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells.
    Mol Cell Biol. 1988 Mar;8(3):1019-26 PMID: 2897079
  30. Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
    Mol Cell Biol. 1987 Jun;7(6):2201-11 PMID: 3110603
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1992-02-15
Pages
1330-4
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC48443
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com